Teucrium Sugar Fund (CANE) Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CANE SEC filings page.
This page shows Teucrium Sugar Fund (CANE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Reported results behave like a commodity fund’s asset-value record, not like an operating company with recurring sales and margins.
Across FY2022-FY2024, net losses became less severe as total assets fell from$505.5M to$241.7M , a pattern more consistent with a shrinking marked portfolio than improving operating economics.
The swing from a net gain in FY2021 to a net loss in FY2022, alongside assets rising from
The FY2025 net loss narrowed to
Financial Health Signals
Teucrium Sugar Fund does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Teucrium Sugar Fund reported $30.4M in net income in Q1 2026. This represents an increase of 1077.9% from the same quarter a year earlier. Against the prior quarter it is up 1077.9%.
Not reported for Q1 2026.
Not reported for Q1 2026.
Not reported for Q1 2026.
Cash & Balance Sheet
Teucrium Sugar Fund held $641.4M in cash as of Q1 2026; long-term debt is not reported for that period.
Not reported for Q1 2026.
Not reported for Q1 2026.
Margins & Returns
None of these metrics is reported for Q1 2026.
Capital Allocation
None of these metrics is reported for Q1 2026.
CANE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $2.0M | N/A | N/A | $11.1M | N/A |
| SG&A Expenses | N/A | N/A | N/A | $71K+34.2% | $78K-36.8% | $71K+44.2% | $55K | $53K+12.9% |
| Interest Expense | N/A | N/A | N/A | $3.0M-34.3% | $3.5M-16.0% | $3.7M-14.5% | $4.6M | $4.6M+35.9% |
| Net Income | $30.4M+1077.9% | -$3.1M+86.8% | N/A | -$56K+99.8% | -$10.9M+52.1% | -$23.5M+22.8% | $8.8M | -$29.0M-416.0% |
| EPS (Basic) | N/A | N/A | N/A | N/A | N/A | $1.05-45.6% | N/A | N/A |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA, Income Tax, EPS (Diluted), Diluted Shares (Avg).
CANE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | N/A | $241.7M-25.9% | $257.4M-30.2% | $268.0M-26.5% | $296.7M-24.4% | $326.0M-35.5% | $369.0M |
| Cash & Equivalents | $641.4M+235.6% | $191.2M-24.7% | $210.9M-27.8% | $233.3M-27.7% | $228.1M-26.7% | $253.7M-23.2% | $292.2M-32.7% | $322.5M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | N/A | N/A | $17.0M+49.4% | $10.2M-62.8% | $27.0M-40.6% | $18.9M-46.5% | $11.4M-71.6% | $27.4M |
| Total Equity | N/A | N/A | $224.6M-28.6% | $247.2M-27.6% | $241.0M-24.5% | $277.8M-22.2% | $314.5M-32.4% | $341.6M |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities, Long-Term Debt, Retained Earnings.
CANE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | -$1.6M+95.8% | $199K+103.3% | -$25.5M-50.2% | $5.6M | -$38.3M-67.9% |
| Financing Cash Flow | N/A | N/A | N/A | $6.9M-86.2% | -$25.8M-96.5% | -$13.1M+85.0% | -$35.9M | $49.8M+134.0% |
| Share Buybacks | N/A | N/A | N/A | $25.3M-34.2% | $47.8M-19.5% | $26.9M-75.8% | $56.4M | $38.4M-83.8% |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid.
CANE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|
| Net Margin | N/A | N/A | N/A | -2.8% | N/A | N/A | 79.3% | N/A |
| Return on Equity | N/A | N/A | N/A | 0.0%+8.5pp | -4.5%+2.6pp | -8.5%+0.1pp | 2.8% | -8.5% |
| Return on Assets | N/A | N/A | N/A | 0.0%+7.8pp | -4.1%+2.2pp | -7.9%-0.2pp | 2.7% | -7.9% |
| Debt-to-Equity | N/A | N/A | 0.080.0x | 0.040.0x | 0.110.0x | 0.070.0x | 0.040.0x | 0.08 |
| Asset Turnover | N/A | N/A | N/A | 0.01+0.1x | -0.030.0x | -0.070.0x | 0.03 | -0.07 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Where Teucrium Sugar Fund Ranks
Frequently Asked Questions
Is Teucrium Sugar Fund profitable?
No, Teucrium Sugar Fund (CANE) reported a net income of -$26.5M in fiscal year 2025.